Korea Research Institute of Bioscience and Biotechnology:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Korea Research Institute of Bioscience and Biotechnology - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8182
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute which provides bioinformatic services. The institute operates in the fields of strategic research, biomedical sciences, system biology and bioengineering, business development, and bioinfrastructure. It offers services including integrated biotechnology, new drug discovery, novel biomaterials and bio-information. KRIBB offers research services through Bioconvergence Research Institute, Super-Bacteria Research Center, BioNanotechnology Research Center, and Biochemicals and Synthetic Biology Research Center. Its strategic research projects include Korea Biosafety Clearing House, Biotech Policy Research Center, Viral Infectious Disease Research Center and Stem Cell Research Center, among others. It operates through its offices located in Daejeon, Cheongju and Jeongeup, South Korea. KRIBB is headquartered in Daejeon, South Korea.

Korea Research Institute of Bioscience and Biotechnology – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Korea Research Institute of Bioscience and Biotechnology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Korea Research Institute of Bioscience and Biotechnology, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Korea Research Institute of Bioscience and Biotechnology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Korea Research Institute of Bioscience and Biotechnology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Korea Research Institute of Bioscience and Biotechnology, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Korea Research Institute of Bioscience and Biotechnology, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Korea Research Institute of Bioscience and Biotechnology and Armed Forces Medical Research Institute to Enter into Partnership 10
Korea Research Institute of Bioscience and Biotechnology and Keimyung University to Enter into Partnership 11
Licensing Agreements 12
Aju Pharm Enters into Licensing Agreement with Korea Research Institute of Bioscience and Biotechnology 12
Korea Research Institute of Bioscience and Biotechnology – Key Competitors 13
Korea Research Institute of Bioscience and Biotechnology – Key Employees 14
Korea Research Institute of Bioscience and Biotechnology – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Strategy And Business Planning 16
Feb 22, 2017: KRIBB established the foundation for the industrialization of overseas biological resources 16
Government and Public Interest 18
Dec 21, 2017: Identified the mechanism of apoptosis gene that is involved in the resistance to cancer treatment 18
Nov 24, 2017: Identified antimicrobial materials in native microorganism in Uleungdo Island 20
Oct 27, 2017: Identifying the gene that causes autism, finding a clue to the development of treatment 22
Sep 26, 2017: Identification of new micro RNA that can control the differentiation of immune cells in bowels 24
Sep 08, 2017: Identification of new protein function that activates the harmful protein dissolution in the cell 26
Jul 18, 2017: Development of new algorithm to measure the completeness of artificial liver organoid 28
Jun 27, 2017: Method of visualizing bacteria small protocol is standardized 30
Jun 08, 2017: Improving the efficiency in new drug development based on nano-bio convergence technology 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Korea Research Institute of Bioscience and Biotechnology, Pharmaceuticals & Healthcare, Key Facts 2
Korea Research Institute of Bioscience and Biotechnology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Korea Research Institute of Bioscience and Biotechnology, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Korea Research Institute of Bioscience and Biotechnology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Korea Research Institute of Bioscience and Biotechnology, Deals By Therapy Area, 2012 to YTD 2018 8
Korea Research Institute of Bioscience and Biotechnology, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Korea Research Institute of Bioscience and Biotechnology and Armed Forces Medical Research Institute to Enter into Partnership 10
Korea Research Institute of Bioscience and Biotechnology and Keimyung University to Enter into Partnership 11
Aju Pharm Enters into Licensing Agreement with Korea Research Institute of Bioscience and Biotechnology 12
Korea Research Institute of Bioscience and Biotechnology, Key Competitors 13
Korea Research Institute of Bioscience and Biotechnology, Key Employees 14
Korea Research Institute of Bioscience and Biotechnology, Other Locations 15

List of Figures
Korea Research Institute of Bioscience and Biotechnology, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Korea Research Institute of Bioscience and Biotechnology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Korea Research Institute of Bioscience and Biotechnology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Korea Research Institute of Bioscience and Biotechnology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Korea Research Institute of Bioscience and Biotechnology, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Korea Research Institute of Bioscience and Biotechnology, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Korea Research Institute of Bioscience and Biotechnology, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Korea Research Institute of Bioscience and Biotechnology, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Korea Research Institute of Bioscience and Biotechnology:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Solent NHS Trust:企業の戦略的SWOT分析
    Solent NHS Trust - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • VERBIO Vereinigte BioEnergie AG (VBK):企業の財務・戦略的SWOT分析
    VERBIO Vereinigte BioEnergie AG (VBK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Memry Corp:企業の戦略的SWOT分析
    Memry Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Gentex Corporation:企業の戦略・SWOT・財務情報
    Gentex Corporation - Strategy, SWOT and Corporate Finance Report Summary Gentex Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • GW Pharmaceuticals Plc (GWPH):企業の財務・戦略的SWOT分析
    GW Pharmaceuticals Plc (GWPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Eastman Kodak Company:戦略・SWOT・企業財務分析
    Eastman Kodak Company - Strategy, SWOT and Corporate Finance Report Summary Eastman Kodak Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Bellerophon Therapeutics Inc (BLPH):企業の財務・戦略的SWOT分析
    Summary Bellerophon Therapeutics Inc (Bellerophon Therapeutics), formerly Known as Bellerophon Therapeutics LLC is a clinical-stage biotherapeutics company that focuses on the development of therapies for the treatment of cardiopulmonary diseases. The company’s lead investigational cardiopulmonary p …
  • Reliance Industries Limited:企業の戦略・SWOT・財務分析
    Reliance Industries Limited - Strategy, SWOT and Corporate Finance Report Summary Reliance Industries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Findel plc:企業の戦略・SWOT・財務情報
    Findel plc - Strategy, SWOT and Corporate Finance Report Summary Findel plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Cutera Inc (CUTR):企業の製品パイプライン分析2018
    Summary Cutera Inc (Cutera) is a medical device company that manufactures, designs, markets, and services medical and aesthetic devices. The company provides laser and energy based aesthetics systems such as pico technology, excel HR technology, excel V technology, Juliet technology, secret RF techn …
  • ACWA Power International:企業の戦略的SWOT分析
    ACWA Power International - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Getronics NV:企業の戦略的SWOT分析
    Getronics NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Biognosys AG-製薬・医療分野:企業M&A・提携分析
    Summary Biognosys AG (Biognosys) is a proteomics company that provides products and services for highly multiplexed protein quantification. The company offers products such as data independent acquisition data analysis software, smartest multiple reaction monitoring and parallel reaction monitoring …
  • Targovax ASA (TRVX):製薬・医療:M&Aディール及び事業提携情報
    Summary Targovax ASA (Targovax) is a developer and commercializer of immunotherapies for the treatment of cancer patients. The company’s lead candidates include TG0, a peptide-based therapeutic anti-cancer vaccine under development for pancreatic cancer; and ONCOS-102 is an adenovirus-based pipeline …
  • Genocea Biosciences Inc (GNCA):製薬・医療:M&Aディール及び事業提携情報
    Summary Genocea Biosciences Inc (Genocea), formerly GenoceaInc, is a cancer vaccines provider. The company discovers and develops T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer. It provides Gen-009 and Gen-010 neoantigen cancer Vaccine pipeline.Genoceaatlas tech …
  • Turkish Aerospace Industries Inc:企業の戦略・SWOT・財務分析
    Turkish Aerospace Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Turkish Aerospace Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Bilfinger SE:企業のM&A・事業提携・投資動向
    Bilfinger SE - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bilfinger SE Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • EQUATE Petrochemical Co:企業の戦略的SWOT分析
    EQUATE Petrochemical Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Selcia Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Selcia Ltd (Selcia), formerly SCYNEXIS Europe Ltd is a contract research company that offers drug discovery services. The company operates through its divisions including selcia discovery - a drug discovery operation, incorporating proprietary fragment screening; and Selcia Radiolabeling - t …
  • Electricity Generating Public Co Ltd:企業の発電所・SWOT分析2018
    Electricity Generating Public Co Ltd - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆